AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox

Longboard Pharmaceuticals stock gained as the company announced positive topline data from its PACIFIC Study evaluating bexicaserin for the treatment of Developmental and Epileptic Encephalopathies (DEEs).

$DOGZ(DOGZ)DOGZ--$LBPH(LBPH)LBPH--$CORT(CORT)CORT--$SNTG(SNTG)SNTG--
Conocer el mercado de acciones hoy al instante
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet